Novel Para-Aminobenzoic Acid Analogs and Their Potential Therapeutic Applications
Abstract
:1. Introduction
1.1. Chemistry of Para-Amino Benzoic Acid
1.2. p-Aminobenzoic Acid as a Biological Scaffold
2. Derivatization of p-Aminobenzoic Acids
2.1. Synthesis of Anti-Cholinesterase Agents
2.2. Anti-Cholinesterases Activity
3. Synthesis of Antimicrobial Agents
Antimicrobial Activity
4. Synthesis of Anticancer Agents
Anticancer Activity
5. Synthesis of Anti-Inflammatory Agents
Anti-Inflammatory Activities
6. Synthesis of Antiviral Agents
7. Future Perspectives and Challenges
8. Conclusions
Funding
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Chen, L.; Wang, Z.; Qiu, T.; Sun, R.; Zhao, Z.; Tian, L.; Liu, X. Synthesis, structural characterization, and properties of triorganotin complexes of Schiff base derived from 3-aminobenzoic acid and salicylaldehyde or 2,4-pentanedione. Appl. Organomet. Chem. 2020, 34, e5790. [Google Scholar] [CrossRef]
- Al-Saffar, R.S.; Zakaria, S.A.; Othman, N.S. Spectrophotometric Determination of p-aminobenzoic acid via Diazotization and Coupling reaction. Res. J. Pharm. Technol. 2021, 14, 5313–5318. [Google Scholar] [CrossRef]
- Bobrovs, R.; Drunka, L.; Auzins, A.A.; Jaudzems, K.; Salvalaglio, M. Polymorph-selective role of hydrogen bonding and π–π stacking in p-aminobenzoic acid solutions. Cryst. Growth Des. 2020, 21, 436–448. [Google Scholar] [CrossRef]
- Meir, Z.; Osherov, N. Vitamin biosynthesis as an antifungal target. J. Fungi 2018, 4, 72. [Google Scholar] [CrossRef]
- DiNardo, J.C.; Downs, C.A. Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone/benzophenone-3. J. Cosmet. Dermatol. 2018, 17, 15–19. [Google Scholar] [CrossRef]
- Al-Rubaie, A.Z.; Al-Jadaan, S.A.S.; Al-Wahed, A.T.A.; Raadah, I.A. Synthesis, characterization and biological studies of some new organometallic compounds containing mercury, selenium and tellurium based on p-aminobenzoic acid. J. Phys. Conf. Ser. 2021, 2063, 012003. [Google Scholar] [CrossRef]
- Cismesia, A.P.; Nicholls, G.R.; Polfer, N.C. Amine vs. carboxylic acid protonation in ortho-, meta-, and para-aminobenzoic acid: An IRMPD spectroscopy study. J. Mol. Spectrosc. 2017, 332, 79–85. [Google Scholar] [CrossRef]
- Bousis, S.; Setyawati, I.; Diamanti, E.; Slotboom, D.J.; Hirsch, A.K.H. Energy-coupling factor transporters as novel antimicrobial targets. Adv. Ther. 2019, 2, 1800066. [Google Scholar] [CrossRef]
- Garrett, G.S.; Bailey, L.B. A public health approach for preventing neural tube defects: Folic acid fortification and beyond. Ann. N. Y. Acad. Sci. 2018, 1414, 47–58. [Google Scholar] [CrossRef]
- Andlid, T.A.; D’Aimmo, M.R.; Jastrebova, J. Folate and bifidobacteria. In The Bifidobacteria and Related Organisms; Elsevier: Amsterdam, The Netherlands, 2018; pp. 195–212. [Google Scholar]
- Nisa, Z.U.; Akhtar, T. Para-aminobenzoic acid-A substrate of immense significance. Mini-Rev. Org. Chem. 2020, 17, 686–700. [Google Scholar] [CrossRef]
- Nichols, B.L.; Chen, J.; Mischnick, P.; Edgar, K.J. Selective oxidation of 2-hydroxypropyl ethers of cellulose and dextran: Simple and efficient introduction of versatile ketone groups to polysaccharides. Biomacromolecules 2020, 21, 4835–4849. [Google Scholar] [CrossRef] [PubMed]
- Ehzari, H.; Amiri, M.; Safari, M.; Samimi, M. Zn-based metal-organic frameworks and p-aminobenzoic acid for electrochemical sensing of copper ions in milk and milk powder samples. Int. J. Environ. Anal. Chem. 2022, 102, 4364–4377. [Google Scholar] [CrossRef]
- Horozić, E.; Ademović, Z.; Suljagić, J.; Cipurković, A.; Roša, E.; Sejfić, A.; Husejnagić, D.; Hodžić, S. Synthesis, spectral characterization, antibacterial and antifungal activity of copper (II)-pABA Complex. Technol. Acta Sci. Prof. J. Chem. Technol. 2019, 12, 27–30. [Google Scholar]
- Cruz-Cabeza, A.J.; Davey, R.J.; Sachithananthan, S.S.; Smith, R.; Tang, S.K.; Vetter, T.; **, molecular docking, chemical synthesis of some novel pyrrolyl benzamide derivatives and evaluation of their inhibitory activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis. Bioorgan. Chem. 2018, 81, 440–453. [Google Scholar] [CrossRef] [PubMed]
- Choudhury, A.A.K.; Vinayagam, S.; Adhikari, N.; Ghosh, S.K.; Sattu, K. Microwave synthesis and antimalarial screening of novel 4-amino benzoic acid (PABA)-substituted pyrimidine derivatives as Plasmodium falciparum dihydrofolate reductase inhibitors. 3 Biotech 2022, 12, 170. [Google Scholar] [CrossRef] [PubMed]
- Dhoke, M.V.; Preethishree, C.; Verma, U.; Sowmya, B.A. Design and Synthesis and Biological Evaluation of Antibacterial Agents. World J. Pharm. Res. 2020, 9, 933–953. [Google Scholar]
- Sharma, S.K. Synthesis and In-Vitro Biological Evaluation of Bezimidazole Derivative. World J. Pharm. Res. 2021, 10, 928–941. [Google Scholar]
- Ali, Y.; Bunnori, N.M.; Susanti, D.; Alhassan, A.M.; Hamid, S.A. Synthesis, in-vitro and in silico studies of azo-based calix [4] arenes as antibacterial agent and neuraminidase inhibitor: A new look into an old scaffold. Front. Chem. 2018, 6, 210. [Google Scholar] [CrossRef]
- Zaltariov, M.-F.; Avadanei, M.; Balan, M.; Peptanariu, D.; Vornicu, N.; Shova, S. Synthesis, structural characterization and biological studies of new Schiff bases containing trimethylsilyl groups. J. Mol. Struct. 2019, 1175, 624–631. [Google Scholar] [CrossRef]
- Ali, F.J.; Radhi, E.R.; Ali, K.J. Synthesis and Characterization of a New Azo Ligand Derivative from 4, 5-BIS (4-Methoxyphenyl) Imidazol and its Metal Complexes and Biological Activity Study of its PD (II) Complex. Pak. J. Med. Health Sci. 2022, 16, 431. [Google Scholar] [CrossRef]
- Alradaa, Z.A.A.; Kadam, Z.M. Preparation, Characterization and Prevention Biological pollution of 4 (4-Benzophenylazo) Pyrogallol and their Metal Complexes. In IOP Conference Series: Earth and Environmental Science; IOP Publishing: Bristol, UK, 2021. [Google Scholar]
- Marinescu, M.; Cinteză, L.O.; Marton, G.I.; Chifiriuc, M.-C.; Popa, M.; Stănculescu, I.; Zălaru, C.-M.; Stavarache, C.-E. Synthesis, density functional theory study and in vitro antimicrobial evaluation of new benzimidazole Mannich bases. BMC Chem. 2020, 14, 45. [Google Scholar] [CrossRef] [PubMed]
- Alam, S.A.M.F.; Ahmad, T.; Nazmuzzaman, M.; Ray, S.K.; Sharifuzzaman, M.; Karim, M.R.; Alam, M.G.; Ajam, M.M.; Maitra, P.; Mandol, D.; et al. Synthesis of benzimidazole derivatives containing schiff base exhibiting antimicrobial activities. Int. J. Res. Stud. Biosci. 2017, 5, 18–24. [Google Scholar]
- Kosti, P.; Naikoo, G.A.; Das, R.; Mishra, N.; Kashaw, S. Biological and electrochemical studies of Co2+, Ni2+, Cu2+, Zn2+ and Cd2+ metal complexes of Schiff base ligand derived from 4-amino benzoic acid and isonicotinic hydrazide. J. Iran. Chem. Soc. 2021, 18, 1773–1780. [Google Scholar] [CrossRef]
- Chaurasia, S.; Dhanalaxmi, C.; Awanija, C.; Tahreem, M.; Nahid, S.; Bharati, M.D. Synthesis, Characterization And Antimicrobial Evaluation of 1, 2,4-Triazole Benzoic Acid Derivatives. Int. J. Adv. Res. Med. Pharm. Sci. 2020, 5, 5–8. [Google Scholar]
- Kamaruzaman, N.A.; Leong, Y.-H.; Jaafar, M.H.; Khan, H.R.M.; Rani, N.A.A.; Razali, M.F.; Majid, M.I.A. Epidemiology and risk factors of pesticide poisoning in Malaysia: A retrospective analysis by the National Poison Centre (NPC) from 2006 to 2015. BMJ Open 2020, 10, e036048. [Google Scholar] [CrossRef] [PubMed]
- Al-Fakeh, M.S.; Alsaedi, R.O.; Amiri, N.; Allazzam, G.A. Synthesis, Characterization, and Antimicrobial of MnO and CdO Nanoparticles by Using a Calcination Method. Coatings 2022, 12, 215. [Google Scholar] [CrossRef]
- Marc, G.; Oniga, S.; Pirnau, A.; Duma, M.; Vlase, L.; Oniga, O. Rational Synthesis of Some New para-Aminobenzoic Acid Hybrids with Thiazolidin-2,4-diones with Antimicrobial Properties. Rev. Chim. 2019, 70, 769–775. [Google Scholar] [CrossRef]
- Saleh, O.R.; Shaldum, M.A.; Goda, R.M.; Shehata, I.A.; El-Ashmawy, M.B. Synthesis and Antibacterial Evaluation of New2-Phenylbenzimidazole Derivatives. ChemistrySelect 2019, 4, 10307–10315. [Google Scholar] [CrossRef]
- Ejidike, I.P.; Bamigboye, M.O.; Njoku, C.B.; Lawal, M. Metal (II) Complexes of some Carboxylic group Drugs: Chelation, Characterization, Antibacterial, Analgesic, and Toxicology Studies. Iran. J. Pharm. Sci. 2021, 17, 47–64. [Google Scholar]
- Ai, J.; Lv, M.; Li, X.; Chen, Z.; Hu, G.; Li, Q. Synthesis, anti-lung cancer activity and molecular docking study of 3-methylene-2-oxoindoline-5-carboxamide derivatives. Med. Chem. Res. 2018, 27, 161–170. [Google Scholar] [CrossRef]
- Narva, S.; Chitti, S.; Amaroju, S.; Goud, S.; Alvala, M.; Bhattacharjee, D.; Jain, N.; Kondapalli Venkata Gowri, C.S. Design, Synthesis, and Biological Evaluation of 2-(4-Aminophenyl) benzothiazole Analogues as Antiproliferative Agents. J. Heterocycl. Chem. 2019, 56, 520–532. [Google Scholar] [CrossRef]
- He, F.; Cong, W.; Yin, C.; Li, C.; Zhao, S.; Wu, Z.; Hu, H.; Fang, M. Design, synthesis, and biological evaluation of (E)-N′-substitute-4-((4-pyridylpyrimidin-2-yl) amino) benzohydrazide derivatives as novel potential CDK9 inhibitors. Arab. J. Chem. 2022, 15, 104039. [Google Scholar] [CrossRef]
- Qin, J.; Liu, J.; Wu, C.; Xu, J.; Tang, B.; Guo, K.; Chen, X.; Liu, W.; Wu, T.; Zhou, H.; et al. Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino) benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. J. Enzym. Inhib. Med. Chem. 2020, 35, 880–896. [Google Scholar] [CrossRef] [PubMed]
- Ran, F.; Li, W.; Qin, Y.; Yu, T.; Liu, Z.; Zhou, M.; Liu, C.; Qiao, T.; Li, X.; Yousef, R.G.; et al. Inhibition of vascular smooth muscle and cancer cell proliferation by new VEGFR inhibitors and their immunomodulator effect: Design, synthesis, and biological evaluation. Oxidative Med. Cell. Longev. 2021, 2021, 8321400. [Google Scholar] [CrossRef] [PubMed]
- Liu, R.; Zhang, Z.; Yang, H.; Zhou, K.; Geng, M.; Zhou, W.; Zhang, M.; Huang, X.; Li, Y. Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors. Eur. J. Med. Chem. 2019, 180, 171–190. [Google Scholar] [CrossRef] [PubMed]
- Abdellatif, K.R.A.; Abdelall, E.K.A.; Abdelgawad, M.A.; Amin, D.M.E.; Omar, H.A. Design, synthesis and biological evaluation of new 4-(4-substituted-anilino) quinoline derivatives as anticancer agents. Med. Chem. Res. 2017, 26, 929–939. [Google Scholar] [CrossRef]
- Mohamed, M.-A.; Mohamed, Y.; Eid, N.M.; Barsoum, F.F. Synthesis and biological evaluation of some heterocyclic compounds. J. Appl. Pharm. Res. 2018, 6, 1–15. [Google Scholar]
- Li, X.Y.; Liang, J.W.; Zhang, T.J.; Lu, G.Q.; Meng, F.H. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs. Eur. J. Med. Chem. 2018, 154, 267–279. [Google Scholar] [CrossRef]
- Elkaeed, E.B.; Yousef, R.G.; Elkady, H.; Gobaara, I.M.M.; Alsfouk, B.A.; Husein, D.Z.; Ibrahim, I.M.; Metwaly, A.M.; Eissa, I.H. Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects. Molecules 2022, 27, 4606. [Google Scholar] [CrossRef]
- Elkady, H.; Elwan, A.; El-Mahdy, H.A.; Doghish, A.S.; Ismail, A.; Taghour, M.S.; Elkaeed, E.B.; Eissa, I.H.; Dahab, M.A.; Mahdy, H.A.; et al. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies. J. Enzym. Inhib. Med. Chem. 2022, 37, 403–416. [Google Scholar] [CrossRef]
- Zsóri, G.; Illés, D.; Terzin, V.; Ivány, E.; Czakó, L. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: Do we need to treat it? A systematic review. Pancreatology 2018, 18, 559–565. [Google Scholar] [CrossRef] [PubMed]
- Konakanchi, R.; Pamidimalla, G.S.; Prashanth, J.; Naveen, T.; Kotha, L.R. Structural elucidation, theoretical investigation, biological screening and molecular docking studies of metal (II) complexes of NN donor ligand derived from 4-(2-aminopyridin-3-methylene) aminobenzoic acid. BioMetals 2021, 34, 529–556. [Google Scholar] [CrossRef] [PubMed]
- Haggam, R.A.; Assy, M.G.; Sherif, M.H.; Galahom, M.M. Facile synthesis of some condensed 1, 3-thiazines and thiazoles under conventional conditions: Antitumor activity. Res. Chem. Intermed. 2017, 43, 6299–6315. [Google Scholar] [CrossRef]
- Hassan, F.; Hairunisa, N.; Mohammed, S.A.; Yousif, E. A study on antitumor effect of 1, 3, 4-thiadiazole derivatives in prostate and breast cancer cell lines (in vitro). Preprints 2017, 2017030053. [Google Scholar] [CrossRef]
- Noser, A.A.; El-Naggar, M.; Donia, T.; Abdelmonsef, A.H. Synthesis, in silico and in vitro assessment of new quinazolinones as anticancer agents via potential AKT inhibition. Molecules 2020, 25, 4780. [Google Scholar] [CrossRef] [PubMed]
- El-Adl, K.; El-Helby, A.G.A.; Sakr, H.; Ayyad, R.R.; Mahdy, H.A.; Nasser, M.; Abulkhair, H.S.; El-Hddad, S.S. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro) benzylidene] thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Der Pharm. 2021, 354, 2000279. [Google Scholar] [CrossRef]
- El-Zahabi, H.S.A.; Nossier, E.S.; Mousa, S.M.; Hassan, H.; Shalaby, A.S.G.; Arafa, R.K. Antibacterial and anticancer profiling of new benzocaine derivatives: Design, synthesis, and molecular mechanism of action. Arch. Der Pharm. 2022, 355, 2100451. [Google Scholar] [CrossRef]
- Tahlan, S.; Ramasamy, K.; Lim, S.M.; Shah, S.A.A.; Mani, V.; Narasimhan, B. 4-(2-(1H-Benzo [d] imidazol-2-ylthio) acetamido)-N-(substituted phenyl) benzamides: Design, synthesis and biological evaluation. BMC Chem. 2019, 13, 12. [Google Scholar] [CrossRef]
- Oufqir, Y.; Fortin, L.; Girouard, J.; Cloutier, F.; Cloutier, M.; Leclerc, M.-F.; Belgorosky, D.; Eiján, A.M.; Bérubé, G.; Reyes-Moreno, C. Synthesis of new para-aminobenzoic acid derivatives, in vitro biological evaluation and preclinical validation of DAB-2-28 as a therapeutic option for the treatment of bladder cancer. Eur. J. Med. Chem. Rep. 2022, 6, 100069. [Google Scholar] [CrossRef]
- Zhang, L.; Li, X.; Chen, Y.; Wan, M.; Jiang, Q.; Zhang, L.; Chou, C.J.; Song, W.; Zhang, L. Discovery of N-(2-Aminophenyl)-4-(bis (2-chloroethyl) amino) benzamide as a potent histone deacetylase inhibitor. Front. Pharmacol. 2019, 10, 957. [Google Scholar] [CrossRef]
- Shabaan, M.A.; Kamal, A.M.; Faggal, S.I.; Elsahar, A.E.; Mohamed, K.O. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase. Archiv Der Pharm. 2020, 353, 1900308. [Google Scholar] [CrossRef] [PubMed]
- Ahmaditaba, M.A.; Shahosseini, S.; Daraei, B.; Zarghi, A.; Houshdar Tehrani, M.H. Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX-2 Inhibitors. Arch. Der Pharm. 2017, 350, 1700158. [Google Scholar] [CrossRef] [PubMed]
- Eswayah, A.; Saad, S.E.; Khaliel, S.; Shamash, A.; Elmelady, M.; Kamour, R.; Elhaddad, E.; Alghali, D. Evaluation of antioxidant, analgesic and anti-inflammatory activity of 2-(4-aminophenyl) benzimidazole-based Schiff bases. IOSR J. Pharm. 2020, 10, 48–56. [Google Scholar]
- Kuchana, M.; Kambala, L.B. Design, synthesis and in silico prediction of drug-likeness properties of new ortho, meta and para-(2-cyano-3-(3, 5-di-tert-butyl-4-hydroxyphenyl) acrylamido) benzoic acids. J. Appl. Pharm. Sci. 2021, 11, 31–35. [Google Scholar]
- Attallah, K.M.; Gouda, A.M.; Ibrahim, I.T.; Abouzeid, L. Design, synthesis, 99mTc labeling, and biological evaluation of a novel pyrrolizine derivative as potential anti-inflammatory agent. Radiochemistry 2017, 59, 630–638. [Google Scholar] [CrossRef]
- Sepehri, S.; Soleymani, S.; Zabihollahi, R.; Aghasadeghi, M.R.; Sadat, M.; Saghaie, L.; Fassihi, A. Synthesis, biological evaluation, and molecular docking studies of novel 4-[4-Arylpyridin-1 (4H)-yl] benzoic acid derivatives as anti-HIV-1 agents. Chem. Biodivers. 2017, 14, e1700295. [Google Scholar] [CrossRef]
- Zhang, C.; Tang, Y.-S.; Meng, C.-R.; Xu, J.; Zhang, D.-L.; Wang, J.; Huang, E.-F.; Shaw, P.-C.; Hu, C. Design, Synthesis, Molecular Docking Analysis and Biological Evaluations of 4-[(Quinolin-4-yl) amino] benzamide Derivatives as Novel Anti-Influenza Virus Agents. Int. J. Mol. Sci. 2022, 23, 6307. [Google Scholar] [CrossRef]
- Hamdani, S.S.; Khan, B.A.; Hameed, S.; Batool, F.; Saleem, H.N.; Mughal, E.U.; Saeed, M. Synthesis and evaluation of novel S-benzyl-and S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids as inhibitors of dengue virus protease. Bioorgan. Chem. 2020, 96, 103567. [Google Scholar] [CrossRef]
- Hasan, E.; Ali, S.N.; Bano, Z.; Begum, S.; Ali, S.; Shams, A.; Siddiqui, B.S. An efficient synthesis of O-and N-alkyl derivatives of 4-aminobenzoic acid and evaluation of their anticancer properties. Nat. Prod. Res. 2023, 1–11. [Google Scholar] [CrossRef]
- Elmetwally, S.A.; Saied, K.F.; Eissa, I.H.; Elkaeed, E.B. Design, synthesis and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Bioorgan. Chem. 2019, 88, 102944. [Google Scholar] [CrossRef]
- Alanazi, M.M.; Eissa, I.H.; Alsaif, N.A.; Obaidullah, A.J.; Alanazi, W.A.; Alasmari, A.F.; Albassam, H.; Elkady, H.; Elwan, A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021, 36, 1760–1782. [Google Scholar] [CrossRef]
- Yousef, R.G.; Elkady, H.; Elkaeed, E.B.; Gobaara, I.M.; Al-Ghulikah, H.A.; Husein, D.Z.; Ibrahim, I.M.; Metwaly, A.M.; Eissa, I.H. (E)-N-(3-(1-(2-(4-(2, 2, 2-Trifluoroacetamido) benzoyl) hydrazono) ethyl) phenyl) nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules 2022, 27, 7719. [Google Scholar] [CrossRef] [PubMed]
- Sun, J.-J.; Wang, J.-P.; Li, T.-Z.; Ma, Y.-B.; Xue, D.; Chen, J.-J. Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma. Med. Chem. Res. 2022, 31, 1224–1239. [Google Scholar] [CrossRef] [PubMed]
- Aquaroni, N.A.S.; Nakahata, D.H.; Lazarini, S.C.; Resende, F.A.; Cândido, A.L.; Barud, H.d.S.; Claro, A.M.; de Carvalho, J.E.; Ribeiro, C.M.; Pavan, F.R.; et al. Antibacterial activities and antiproliferative assays over a tumor cells panel of a silver complex with 4-aminobenzoic acid: Studies in vitro of sustained release using bacterial cellulose membranes as support. J. Inorg. Biochem. 2020, 212, 111247. [Google Scholar] [CrossRef] [PubMed]
- Fonkui, T.Y.; Ikhile, M.I.; Njobeh, P.B.; Ndinteh, D.T. Benzimidazole Schiff base derivatives: Synthesis, characterization and antimicrobial activity. BMC Chem. 2019, 13, 127. [Google Scholar] [CrossRef] [PubMed]
- Kyei, S.K.; Akaranta, O.; Darko, G. Synthesis, characterization and antimicrobial activity of peanut skin extract-azo-compounds. Sci. Afr. 2020, 8, e00406. [Google Scholar] [CrossRef]
- Sweidana, K.A.; Ala’a, M.; Sinib, M.K.A.; Joshi, R. Synthesis, characterization and antimicrobial evaluation of some new substituted 1H-indole-2 carboxamide derivatives. J. Indian Chem. Soc. 2020, 97, 1557–1562. [Google Scholar]
- Shetnev, A.A.; Volobueva, A.S.; Panova, V.A.; Zarubaev, V.V.; Baykov, S.V. Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3. Life 2022, 12, 1832. [Google Scholar] [CrossRef]
- Abdulameer, J.H.; Serih, K.H.; Al Hussain, H.A.A.A. Co(II), Ni(II) and Cu(II) Mononuclear Complexes with N2O2 Ligand. Derived from Ethyl 4-Aminobenzoate. J. Med. Chem. Sci. 2022, 5, 874–880. [Google Scholar]
- Banoo, R.; Nuthakki, V.K.; Abdullaha, M.; Sharma, M.; Bharate, S.B. Blood–brain barrier permeable benzylpiperidin-4-yl-linked benzylamino benzamides as dual cholinesterase inhibitors. Drug Dev. Res. 2022, 83, 1791–1802. [Google Scholar] [CrossRef]
- Guilherme, F.D.; Simonetti, J.; Folquitto, L.R.S.; Reis, A.C.C.; Oliver, J.C.; Dias, A.L.T.; Dias, D.F.; Carvalho, D.T.; Brandão, G.C.; de Souza, T.B. Synthesis, chemical characterization and antimicrobial activity of new acylhydrazones derived from carbohydrates. J. Mol. Struct. 2019, 1184, 349–356. [Google Scholar] [CrossRef]
- Bozkurt, E.; Sıcak, Y.; Oruç-Emre, E.E.; Iyidoğan, A.K.; Öztürk, M. Design and bioevaluation of novel hydrazide-hydrazones derived from 4-acetyl-N-substituted benzenesulfonamide. Russ. J. Bioorgan. Chem. 2020, 46, 702–714. [Google Scholar] [CrossRef]
- Al-Sanea, M.M.; Gotina, L.; Mohamed, M.F.; Grace Thomas Parambi, D.; Gomaa, H.A.; Mathew, B.; Youssif, B.G.; Alharbi, K.S.; Elsayed, Z.M.; Abdelgawad, M.A.; et al. Design, synthesis and biological evaluation of new HDAC1 and HDAC2 inhibitors endowed with ligustrazine as a novel cap moiety. Drug Des. Dev. Ther. 2020, 14, 497–508. [Google Scholar] [CrossRef] [PubMed]
- Chikkula, K.V.; Sundararajan, R. Analgesic, anti-inflammatory, and antimicrobial activities of novel isoxazole/pyrimidine/pyrazole substituted benzimidazole analogs. Med. Chem. Res. 2017, 26, 3026–3037. [Google Scholar] [CrossRef]
Derivatives of PABA | Synthetic Conditions | Characterization Techniques | Physical Properties | Biological Activity | IC50 (µM) | Reference |
---|---|---|---|---|---|---|
Nonyl 4-nonylamino)benzoate | PABA, alkylating agent, K2CO3, acetone, 5–6 h | EIMS, FTIR, 1H-NMR, and 13C NMR | Amorphous white solid | Cytotoxicity activity against the NCI-H460 cell line | NCI-H460: 15.59 | [112] |
4-((5,6,7,8-tetrahydrobenzo [4,5]thieno [2,3-d]pyrimidin-4-yl)amino)benzoic acid | 4-chloro-6,7,8,9-tetrahydro-5H-indeno [2,1-d]pyrimidine, PABA, ethanol, reflux, 4 h | EIMS, FTIR, 1H NMR, and 13C NMR | Yellow crystal, Yield: 88%, m.p: 280–282 °C | Cell lines: EGFRT790M and HER2 kinases and 4 cancer cell lines of HCT-116, HepG2, A431, and MCF-7 | HepG2: 67.72 ± 3.70 HCT-116: 62.57 ± 3.30 MCF-7: 75.75 ± 3.40 | [113] |
N-(tert-butyl)-4-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetamido)benzamide | N-(tert-butyl)-4-(2-chloroacetamido) benzamide, potassium salt of 3-methylquinoxalin-2(1H)-one, DMF, KI, heating 3 h | 1H NMR, 13C NMR, and FTIR | Dark green crystal, Yield: 80%, m.p: 230–232 °C | Cytotoxicity against HepG2 and MCF-7 cell lines | MCF-7: 7.7, HepG2: 4.5 | [114] |
2-(4-((2-Oxoindolin-3-ylidene)amino)benzoyl)-N-phenylhydrazinecarbothioamide | 4-((5-Substituted-2-oxoindolin-3-ylidene)amino)benzohydrazide, Isothiocyanatobenzene, EtOH, Reflux, 8 h. | EIMS, FTIR, 1H NMR, and 13C NMR | Yellow powder, Yield: 93%, m.p: 211–213 °C | Cytotoxic activity against HepG2 cell line, MCF-7 cell line, VEGFR-2 kinase inhibitory assay | MCF-7: 0.74–4.62 HepG2: 1.13–8.81 VEGFR-2: 0.078 | [19] |
((E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide) | 2,2,2-Trifluoro-N-(4-(hydrazinecarbonyl)phenyl)acetamide, N-(3-acetylphenyl)nicotinamide, 6 h and absolute ethanol | EIMS, FTIR, 1H NMR, and 13C NMR | Off-white crystals Yield: 80%, m.p: 246–248 °C | Cytotoxic properties against VEGFR-2, MCF-7 cell lines, and HepG2 | VEGFR-2: 65 nM HepG2: 21.00, MCF-7: 26.10 | [115] |
3α-O-(4-acrylamidebenzoyl)-4β-hydroxy-5,7α,6β(H)-guaia-1(10),11(13)-dien-12,6-olide | 3α,4β-dihydroxy-5,7α,6β(H)-guaia-1(10),11(13)-dien12,6-olide, 4-acrylamidobenzoic acid, DCC, DMAP, CH2Cl2, | 1H NMR, 13C NMR, and HRESIMS | White powder, Yield: 56%, m.p: 120–122 °C | Cytotoxicity against Huh7 and HepG2 cell lines | HepG2: 7.9 ± 0.3 Huh: 78.5 ± 0.2 | [116] |
Ag-PABA complex | PABA, KOH, AgNO3, 1 h | XRD, mass spectrometry, 1H NMR, 2D NMR, and 13C NMR | White solid | In vitro antibacterial activity | MIC value (µM) S. aureus ATCC 25923: 88.5 B. cereus ATCC 14579: 88.5 E. coli: 44.0 | [117] |
4-[1-(1,3-Dihydro-benzoimida-zol-2-ylideneamino)-oct-2-ynylideneamino]-benzoic acid | Oct-2-ynoic acid (1,3-dihydrobenzoimidazole-2-ylidene)amide, aniline derivatives, warm ethanoic solution and refluxing for 4 h | UV–Vis absorption, FTIR, 13C NMR, 1H NMR, and C, H, N elemental analysis | White powder, Yield: 73%, m.p. 175.2 °C | Anti-plasmodial activity | Plasmodium Falciparum 3D7: 28.31 µg/mL | [118] |
Peanut skin extract-azo-compounds and complexes with iron | NaNO2, HCl, ice, peanut skin extract, FeCl2, methanol, 65 °C, reflux 3 h | SEM-EDS analysis, FTIR, and UV-visible spectroscopy | Deep orange, Yield: 56.81%, m.p: > 300 °C | Antimicrobial activity against Staphylococcus aureus and Escherichia coli | Inhibition zone (mm) E. Coli:10.0 ± 0.33 S. aureus: 6.0 ± 1.52 | [119] |
4-(1H-Indole-2-carboxamido)benzoic acid | Dry pyridine, CHCl3,1H-Indole-2-carbonyl chloride | NMR, IR spectroscopy, HRMS, and elemental analysis techniques | Yield: 86%, m.p: 256–258 °C | Antifungal and antibacterial activity | Inhibition zone (mm) C. albicans DSMZ 11949: 9–14 | [120] |
Methyl (S)-2-(4-(4-methylphenylsulfonamido)benzamido)propanoate | Amino acid methyl ester hydrochloride, 4-(4-methylphenylsulfonamido)benzoic acid, DCC, HOBt, DIPEA, THF, | 1H NMR, 13C NMR, and HRMS | Yield: 92%, m.p. 203.1–203.9 °C | In vitro PPRE-activated activity | PPRE-activated activity: 87% | [27] |
2-((4-(N-(4-Carboxyphenyl)sulfamoyl)phenyl)carbamoyl)benzoic acid | 2-((4-(N-(4-(Ethoxycarbonyl)phenyl)sulfamoyl)phenyl)carbamoyl)benzoic acid, NaOH, EtOH, 80 °C, 18 h | 13C NMR, 1H NMR, and HRMS (ESI) | White powder, Yield: 82%, m.p. 203–205 °C | Antiviral activity against Nancy, coxsackievirus B3. CVB3 | CVB3: 4.22 Nancy: 4.29 | [121] |
N,N’-(1,2-phenylene) bis(4-aminobenzamide) and its complexes | ethyl 4-aminobenzoate, 1,2-Benzene diamine, reflux 3 h, MCl2, reflux | UV-Vis, FTIR, 1H NMR, and elemental analyses | Pale green, Yield: 45%, m.p: 230 °C | Antibacterial activity against S. aureus and E. coli | Diameters of antibacterial activity S. aureus: 25 mm E. coli: 28 mm | [122] |
N-(2-(1-benzylpiperidin-4-yl)ethyl)-4-((3,5-dimethoxybenzyl)amino)benzamide | 4-Amino-N-(2-(1-benzylpiperidin-4-yl)ethyl)benzamide, benzyl halide ACN, 80 °C, 6 h, | 13C NMR, 1H NMR, and HRMS (ESI) | Yellow solid, Yield: 80%, m.p: 118–120 °C | Activity against ChE enzymes | AChE: 0.61, BchE: 2.04 | [123] |
N-(4-{[(2E)-2-(4-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside)-3-metoxybenzylidene)hydrazino]carbonyl}phenyl)benzamide | galactoside, N-(4-(hydrazinecarbonyl)phenyl)benzamide, ethyl alcohol, r.t, HCl, stirring for 24 h | 13C NMR, 1H NMR HRMS (ESI), and FTIR | White crystals, Yield: 84%, m.p: 137–138 °C | Antifungal activity | C. glabrata: 695.2 | [124] |
4-(4-(1-(2-Isonicotinoylhydrazono)ethyl)phenylsulfonamido)benzoic acid | Acetylbenzenesulfonamide derivatives, hydrazide derivatives, methanol, 2 h, glacial acetic acid | UV, IR, 1H NMR, 13C NMR, mass spectroscopy, and elemental analysis | White solid, Yield: 41% m.p: 288–290 °C | AChE activity | AChE: 11.12 ± 0.74 | [125] |
N-(3-(Hydroxycarbamoyl)phenyl)-3,5,6-Trimethylpyrazine-2-Carboxamide | 4-(3,5,6-trimethylpyrazine-2-carboxamido)benzoic acid, NH2OH, | 1H NMR | Yield: 52% m.p: >250 °C | Antiproliferative activities against two HDAC-expressing cancer cell lines: HT-29 and SH-SY5Y | HT-29 cells: 1.96 | [126] |
Cu(PABA)2(H2O)2 complex | Metal and ligand 1:2 molar ratio (M:L), 30 min, pH value at 5.6, r.t | FTIR and UV-vis spectroscopy | Dark green product | Antimicrobial activity | Inhibition zone (mm) Enterococcus faecalis: 16 S. aureus: 11 | [14] |
4-(2-(4-(1H-Benzimidazol-2-yl)phenyl)hydrazono)-1-(4-chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-one | Ethyl 2-(2-(4-(1H-benzimidazol-2-yl)phenyl) hydrazono)-3-oxobutanoate, hydrazine hydrochloride, ethanol, refluxed for 12 h | EIMS, FTIR, 1H NMR, and 13C NMR | Yield: 82%, m.p: 197–200 °C | Antimicrobial activity | MIC (µg/mL) S. aureus: 7.81 S. epidermidis: 1.95 E. coli: 7.81 | [127] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Haroon, F.; Farwa, U.; Arif, M.; Raza, M.A.; Sandhu, Z.A.; El Oirdi, M.; Farhan, M.; Alhasawi, M.A.I. Novel Para-Aminobenzoic Acid Analogs and Their Potential Therapeutic Applications. Biomedicines 2023, 11, 2686. https://doi.org/10.3390/biomedicines11102686
Haroon F, Farwa U, Arif M, Raza MA, Sandhu ZA, El Oirdi M, Farhan M, Alhasawi MAI. Novel Para-Aminobenzoic Acid Analogs and Their Potential Therapeutic Applications. Biomedicines. 2023; 11(10):2686. https://doi.org/10.3390/biomedicines11102686
Chicago/Turabian StyleHaroon, Faisal, Umme Farwa, Maimoona Arif, Muhammad Asam Raza, Zeshan Ali Sandhu, Mohamed El Oirdi, Mohd Farhan, and Mohammed Ahmed Ismail Alhasawi. 2023. "Novel Para-Aminobenzoic Acid Analogs and Their Potential Therapeutic Applications" Biomedicines 11, no. 10: 2686. https://doi.org/10.3390/biomedicines11102686